Log In
Print this Print this

sotatercept (formerly ACE-011)

  Manage Alerts
Collapse Summary General Information
Company Acceleron Pharma Inc.
DescriptionSoluble fusion protein consisting of the extracellular domain of activin receptor type 2A (ACVR2A) linked to the Fc protein of human IgGI
Molecular Target Activin receptor type 2A (ACVR2A)
Mechanism of ActionActivin receptor type 2A (ACVR2A) antagonist
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today